Pharma & Healthcare
Global Jakinibs Market Research Report 2024
- Jan 29, 24
- ID: 50477
- Pages: 96
- Figures: 204
- Views: 13
Jakinibs are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.
The global Jakinibs market was valued at US$ 14610 million in 2023 and is anticipated to reach US$ 33210 million by 2030, witnessing a CAGR of 12.4% during the forecast period 2024-2030.
The driving factors of the Janus Kinase (JAK) inhibitor market mainly include the following aspects:
Increase in immune system diseases: JAK inhibitors are commonly used to treat immune system-related diseases such as rheumatoid arthritis, Sjogren's syndrome, inflammatory bowel disease, and psoriasis. As the incidence of these diseases continues to increase, the JAK inhibitor market is also expanding.
Research and development of innovative drugs: Pharmaceutical companies continue to invest in the development of new generations of JAK inhibitors to improve treatment efficacy and reduce side effects. The launch of these innovative drugs drives the growth of the market.
Aging Global Population: As the global population ages, the risk of developing immune system-related diseases increases. This will drive demand for drugs such as JAK inhibitors to address health challenges in the elderly population.
This report aims to provide a comprehensive presentation of the global market for Jakinibs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Jakinibs.
Report Scope
The Jakinibs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Jakinibs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Jakinibs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Astellas Pharma, Inc.
Eli Lilly and Co.
Incyte Corp.
Novartis AG
Pfizer Inc.
GSK
Bristol Myers Squibb Co.
Baxter International, Inc.
Gilead Sciences, Inc.
AbbVie, Inc.
Takeda
Boehringer Ingelheim Group
Teva Pharmaceutical
Kyowa Hakko Kirin Co. Ltd.
Segment by Type
JAK1 Inhibitors
JAK2 Inhibitors
JAK3 Inhibitors
Segment by Application
Rheumatoid Arthritis
Inflammatory Bowel Disease
Psoriasis
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Jakinibs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Jakinibs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Jakinibs market was valued at US$ 14610 million in 2023 and is anticipated to reach US$ 33210 million by 2030, witnessing a CAGR of 12.4% during the forecast period 2024-2030.
The driving factors of the Janus Kinase (JAK) inhibitor market mainly include the following aspects:
Increase in immune system diseases: JAK inhibitors are commonly used to treat immune system-related diseases such as rheumatoid arthritis, Sjogren's syndrome, inflammatory bowel disease, and psoriasis. As the incidence of these diseases continues to increase, the JAK inhibitor market is also expanding.
Research and development of innovative drugs: Pharmaceutical companies continue to invest in the development of new generations of JAK inhibitors to improve treatment efficacy and reduce side effects. The launch of these innovative drugs drives the growth of the market.
Aging Global Population: As the global population ages, the risk of developing immune system-related diseases increases. This will drive demand for drugs such as JAK inhibitors to address health challenges in the elderly population.
This report aims to provide a comprehensive presentation of the global market for Jakinibs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Jakinibs.
Report Scope
The Jakinibs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Jakinibs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Jakinibs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Astellas Pharma, Inc.
Eli Lilly and Co.
Incyte Corp.
Novartis AG
Pfizer Inc.
GSK
Bristol Myers Squibb Co.
Baxter International, Inc.
Gilead Sciences, Inc.
AbbVie, Inc.
Takeda
Boehringer Ingelheim Group
Teva Pharmaceutical
Kyowa Hakko Kirin Co. Ltd.
Segment by Type
JAK1 Inhibitors
JAK2 Inhibitors
JAK3 Inhibitors
Segment by Application
Rheumatoid Arthritis
Inflammatory Bowel Disease
Psoriasis
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Jakinibs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Jakinibs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Jakinibs Market Overview
1.1 Product Overview and Scope of Jakinibs
1.2 Jakinibs Segment by Type
1.2.1 Global Jakinibs Market Value Comparison by Type (2024-2030)
1.2.2 JAK1 Inhibitors
1.2.3 JAK2 Inhibitors
1.2.4 JAK3 Inhibitors
1.3 Jakinibs Segment by Application
1.3.1 Global Jakinibs Market Value by Application: (2024-2030)
1.3.2 Rheumatoid Arthritis
1.3.3 Inflammatory Bowel Disease
1.3.4 Psoriasis
1.3.5 Others
1.4 Global Jakinibs Market Size Estimates and Forecasts
1.4.1 Global Jakinibs Revenue 2019-2030
1.4.2 Global Jakinibs Sales 2019-2030
1.4.3 Global Jakinibs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Jakinibs Market Competition by Manufacturers
2.1 Global Jakinibs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Jakinibs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Jakinibs Average Price by Manufacturers (2019-2024)
2.4 Global Jakinibs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Jakinibs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Jakinibs, Product Type & Application
2.7 Jakinibs Market Competitive Situation and Trends
2.7.1 Jakinibs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Jakinibs Players Market Share by Revenue
2.7.3 Global Jakinibs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Jakinibs Retrospective Market Scenario by Region
3.1 Global Jakinibs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Jakinibs Global Jakinibs Sales by Region: 2019-2030
3.2.1 Global Jakinibs Sales by Region: 2019-2024
3.2.2 Global Jakinibs Sales by Region: 2025-2030
3.3 Global Jakinibs Global Jakinibs Revenue by Region: 2019-2030
3.3.1 Global Jakinibs Revenue by Region: 2019-2024
3.3.2 Global Jakinibs Revenue by Region: 2025-2030
3.4 North America Jakinibs Market Facts & Figures by Country
3.4.1 North America Jakinibs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Jakinibs Sales by Country (2019-2030)
3.4.3 North America Jakinibs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Jakinibs Market Facts & Figures by Country
3.5.1 Europe Jakinibs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Jakinibs Sales by Country (2019-2030)
3.5.3 Europe Jakinibs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Jakinibs Market Facts & Figures by Country
3.6.1 Asia Pacific Jakinibs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Jakinibs Sales by Country (2019-2030)
3.6.3 Asia Pacific Jakinibs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Jakinibs Market Facts & Figures by Country
3.7.1 Latin America Jakinibs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Jakinibs Sales by Country (2019-2030)
3.7.3 Latin America Jakinibs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Jakinibs Market Facts & Figures by Country
3.8.1 Middle East and Africa Jakinibs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Jakinibs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Jakinibs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Jakinibs Sales by Type (2019-2030)
4.1.1 Global Jakinibs Sales by Type (2019-2024)
4.1.2 Global Jakinibs Sales by Type (2025-2030)
4.1.3 Global Jakinibs Sales Market Share by Type (2019-2030)
4.2 Global Jakinibs Revenue by Type (2019-2030)
4.2.1 Global Jakinibs Revenue by Type (2019-2024)
4.2.2 Global Jakinibs Revenue by Type (2025-2030)
4.2.3 Global Jakinibs Revenue Market Share by Type (2019-2030)
4.3 Global Jakinibs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Jakinibs Sales by Application (2019-2030)
5.1.1 Global Jakinibs Sales by Application (2019-2024)
5.1.2 Global Jakinibs Sales by Application (2025-2030)
5.1.3 Global Jakinibs Sales Market Share by Application (2019-2030)
5.2 Global Jakinibs Revenue by Application (2019-2030)
5.2.1 Global Jakinibs Revenue by Application (2019-2024)
5.2.2 Global Jakinibs Revenue by Application (2025-2030)
5.2.3 Global Jakinibs Revenue Market Share by Application (2019-2030)
5.3 Global Jakinibs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Astellas Pharma, Inc.
6.1.1 Astellas Pharma, Inc. Corporation Information
6.1.2 Astellas Pharma, Inc. Description and Business Overview
6.1.3 Astellas Pharma, Inc. Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Astellas Pharma, Inc. Jakinibs Product Portfolio
6.1.5 Astellas Pharma, Inc. Recent Developments/Updates
6.2 Eli Lilly and Co.
6.2.1 Eli Lilly and Co. Corporation Information
6.2.2 Eli Lilly and Co. Description and Business Overview
6.2.3 Eli Lilly and Co. Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eli Lilly and Co. Jakinibs Product Portfolio
6.2.5 Eli Lilly and Co. Recent Developments/Updates
6.3 Incyte Corp.
6.3.1 Incyte Corp. Corporation Information
6.3.2 Incyte Corp. Description and Business Overview
6.3.3 Incyte Corp. Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Incyte Corp. Jakinibs Product Portfolio
6.3.5 Incyte Corp. Recent Developments/Updates
6.4 Novartis AG
6.4.1 Novartis AG Corporation Information
6.4.2 Novartis AG Description and Business Overview
6.4.3 Novartis AG Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis AG Jakinibs Product Portfolio
6.4.5 Novartis AG Recent Developments/Updates
6.5 Pfizer Inc.
6.5.1 Pfizer Inc. Corporation Information
6.5.2 Pfizer Inc. Description and Business Overview
6.5.3 Pfizer Inc. Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Inc. Jakinibs Product Portfolio
6.5.5 Pfizer Inc. Recent Developments/Updates
6.6 GSK
6.6.1 GSK Corporation Information
6.6.2 GSK Description and Business Overview
6.6.3 GSK Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GSK Jakinibs Product Portfolio
6.6.5 GSK Recent Developments/Updates
6.7 Bristol Myers Squibb Co.
6.6.1 Bristol Myers Squibb Co. Corporation Information
6.6.2 Bristol Myers Squibb Co. Description and Business Overview
6.6.3 Bristol Myers Squibb Co. Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bristol Myers Squibb Co. Jakinibs Product Portfolio
6.7.5 Bristol Myers Squibb Co. Recent Developments/Updates
6.8 Baxter International, Inc.
6.8.1 Baxter International, Inc. Corporation Information
6.8.2 Baxter International, Inc. Description and Business Overview
6.8.3 Baxter International, Inc. Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Baxter International, Inc. Jakinibs Product Portfolio
6.8.5 Baxter International, Inc. Recent Developments/Updates
6.9 Gilead Sciences, Inc.
6.9.1 Gilead Sciences, Inc. Corporation Information
6.9.2 Gilead Sciences, Inc. Description and Business Overview
6.9.3 Gilead Sciences, Inc. Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Gilead Sciences, Inc. Jakinibs Product Portfolio
6.9.5 Gilead Sciences, Inc. Recent Developments/Updates
6.10 AbbVie, Inc.
6.10.1 AbbVie, Inc. Corporation Information
6.10.2 AbbVie, Inc. Description and Business Overview
6.10.3 AbbVie, Inc. Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 AbbVie, Inc. Jakinibs Product Portfolio
6.10.5 AbbVie, Inc. Recent Developments/Updates
6.11 Takeda
6.11.1 Takeda Corporation Information
6.11.2 Takeda Jakinibs Description and Business Overview
6.11.3 Takeda Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Takeda Jakinibs Product Portfolio
6.11.5 Takeda Recent Developments/Updates
6.12 Boehringer Ingelheim Group
6.12.1 Boehringer Ingelheim Group Corporation Information
6.12.2 Boehringer Ingelheim Group Jakinibs Description and Business Overview
6.12.3 Boehringer Ingelheim Group Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Boehringer Ingelheim Group Jakinibs Product Portfolio
6.12.5 Boehringer Ingelheim Group Recent Developments/Updates
6.13 Teva Pharmaceutical
6.13.1 Teva Pharmaceutical Corporation Information
6.13.2 Teva Pharmaceutical Jakinibs Description and Business Overview
6.13.3 Teva Pharmaceutical Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Teva Pharmaceutical Jakinibs Product Portfolio
6.13.5 Teva Pharmaceutical Recent Developments/Updates
6.14 Kyowa Hakko Kirin Co. Ltd.
6.14.1 Kyowa Hakko Kirin Co. Ltd. Corporation Information
6.14.2 Kyowa Hakko Kirin Co. Ltd. Jakinibs Description and Business Overview
6.14.3 Kyowa Hakko Kirin Co. Ltd. Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Kyowa Hakko Kirin Co. Ltd. Jakinibs Product Portfolio
6.14.5 Kyowa Hakko Kirin Co. Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Jakinibs Industry Chain Analysis
7.2 Jakinibs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Jakinibs Production Mode & Process
7.4 Jakinibs Sales and Marketing
7.4.1 Jakinibs Sales Channels
7.4.2 Jakinibs Distributors
7.5 Jakinibs Customers
8 Jakinibs Market Dynamics
8.1 Jakinibs Industry Trends
8.2 Jakinibs Market Drivers
8.3 Jakinibs Market Challenges
8.4 Jakinibs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Jakinibs
1.2 Jakinibs Segment by Type
1.2.1 Global Jakinibs Market Value Comparison by Type (2024-2030)
1.2.2 JAK1 Inhibitors
1.2.3 JAK2 Inhibitors
1.2.4 JAK3 Inhibitors
1.3 Jakinibs Segment by Application
1.3.1 Global Jakinibs Market Value by Application: (2024-2030)
1.3.2 Rheumatoid Arthritis
1.3.3 Inflammatory Bowel Disease
1.3.4 Psoriasis
1.3.5 Others
1.4 Global Jakinibs Market Size Estimates and Forecasts
1.4.1 Global Jakinibs Revenue 2019-2030
1.4.2 Global Jakinibs Sales 2019-2030
1.4.3 Global Jakinibs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Jakinibs Market Competition by Manufacturers
2.1 Global Jakinibs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Jakinibs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Jakinibs Average Price by Manufacturers (2019-2024)
2.4 Global Jakinibs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Jakinibs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Jakinibs, Product Type & Application
2.7 Jakinibs Market Competitive Situation and Trends
2.7.1 Jakinibs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Jakinibs Players Market Share by Revenue
2.7.3 Global Jakinibs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Jakinibs Retrospective Market Scenario by Region
3.1 Global Jakinibs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Jakinibs Global Jakinibs Sales by Region: 2019-2030
3.2.1 Global Jakinibs Sales by Region: 2019-2024
3.2.2 Global Jakinibs Sales by Region: 2025-2030
3.3 Global Jakinibs Global Jakinibs Revenue by Region: 2019-2030
3.3.1 Global Jakinibs Revenue by Region: 2019-2024
3.3.2 Global Jakinibs Revenue by Region: 2025-2030
3.4 North America Jakinibs Market Facts & Figures by Country
3.4.1 North America Jakinibs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Jakinibs Sales by Country (2019-2030)
3.4.3 North America Jakinibs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Jakinibs Market Facts & Figures by Country
3.5.1 Europe Jakinibs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Jakinibs Sales by Country (2019-2030)
3.5.3 Europe Jakinibs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Jakinibs Market Facts & Figures by Country
3.6.1 Asia Pacific Jakinibs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Jakinibs Sales by Country (2019-2030)
3.6.3 Asia Pacific Jakinibs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Jakinibs Market Facts & Figures by Country
3.7.1 Latin America Jakinibs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Jakinibs Sales by Country (2019-2030)
3.7.3 Latin America Jakinibs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Jakinibs Market Facts & Figures by Country
3.8.1 Middle East and Africa Jakinibs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Jakinibs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Jakinibs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Jakinibs Sales by Type (2019-2030)
4.1.1 Global Jakinibs Sales by Type (2019-2024)
4.1.2 Global Jakinibs Sales by Type (2025-2030)
4.1.3 Global Jakinibs Sales Market Share by Type (2019-2030)
4.2 Global Jakinibs Revenue by Type (2019-2030)
4.2.1 Global Jakinibs Revenue by Type (2019-2024)
4.2.2 Global Jakinibs Revenue by Type (2025-2030)
4.2.3 Global Jakinibs Revenue Market Share by Type (2019-2030)
4.3 Global Jakinibs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Jakinibs Sales by Application (2019-2030)
5.1.1 Global Jakinibs Sales by Application (2019-2024)
5.1.2 Global Jakinibs Sales by Application (2025-2030)
5.1.3 Global Jakinibs Sales Market Share by Application (2019-2030)
5.2 Global Jakinibs Revenue by Application (2019-2030)
5.2.1 Global Jakinibs Revenue by Application (2019-2024)
5.2.2 Global Jakinibs Revenue by Application (2025-2030)
5.2.3 Global Jakinibs Revenue Market Share by Application (2019-2030)
5.3 Global Jakinibs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Astellas Pharma, Inc.
6.1.1 Astellas Pharma, Inc. Corporation Information
6.1.2 Astellas Pharma, Inc. Description and Business Overview
6.1.3 Astellas Pharma, Inc. Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Astellas Pharma, Inc. Jakinibs Product Portfolio
6.1.5 Astellas Pharma, Inc. Recent Developments/Updates
6.2 Eli Lilly and Co.
6.2.1 Eli Lilly and Co. Corporation Information
6.2.2 Eli Lilly and Co. Description and Business Overview
6.2.3 Eli Lilly and Co. Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eli Lilly and Co. Jakinibs Product Portfolio
6.2.5 Eli Lilly and Co. Recent Developments/Updates
6.3 Incyte Corp.
6.3.1 Incyte Corp. Corporation Information
6.3.2 Incyte Corp. Description and Business Overview
6.3.3 Incyte Corp. Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Incyte Corp. Jakinibs Product Portfolio
6.3.5 Incyte Corp. Recent Developments/Updates
6.4 Novartis AG
6.4.1 Novartis AG Corporation Information
6.4.2 Novartis AG Description and Business Overview
6.4.3 Novartis AG Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis AG Jakinibs Product Portfolio
6.4.5 Novartis AG Recent Developments/Updates
6.5 Pfizer Inc.
6.5.1 Pfizer Inc. Corporation Information
6.5.2 Pfizer Inc. Description and Business Overview
6.5.3 Pfizer Inc. Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Inc. Jakinibs Product Portfolio
6.5.5 Pfizer Inc. Recent Developments/Updates
6.6 GSK
6.6.1 GSK Corporation Information
6.6.2 GSK Description and Business Overview
6.6.3 GSK Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GSK Jakinibs Product Portfolio
6.6.5 GSK Recent Developments/Updates
6.7 Bristol Myers Squibb Co.
6.6.1 Bristol Myers Squibb Co. Corporation Information
6.6.2 Bristol Myers Squibb Co. Description and Business Overview
6.6.3 Bristol Myers Squibb Co. Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bristol Myers Squibb Co. Jakinibs Product Portfolio
6.7.5 Bristol Myers Squibb Co. Recent Developments/Updates
6.8 Baxter International, Inc.
6.8.1 Baxter International, Inc. Corporation Information
6.8.2 Baxter International, Inc. Description and Business Overview
6.8.3 Baxter International, Inc. Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Baxter International, Inc. Jakinibs Product Portfolio
6.8.5 Baxter International, Inc. Recent Developments/Updates
6.9 Gilead Sciences, Inc.
6.9.1 Gilead Sciences, Inc. Corporation Information
6.9.2 Gilead Sciences, Inc. Description and Business Overview
6.9.3 Gilead Sciences, Inc. Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Gilead Sciences, Inc. Jakinibs Product Portfolio
6.9.5 Gilead Sciences, Inc. Recent Developments/Updates
6.10 AbbVie, Inc.
6.10.1 AbbVie, Inc. Corporation Information
6.10.2 AbbVie, Inc. Description and Business Overview
6.10.3 AbbVie, Inc. Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 AbbVie, Inc. Jakinibs Product Portfolio
6.10.5 AbbVie, Inc. Recent Developments/Updates
6.11 Takeda
6.11.1 Takeda Corporation Information
6.11.2 Takeda Jakinibs Description and Business Overview
6.11.3 Takeda Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Takeda Jakinibs Product Portfolio
6.11.5 Takeda Recent Developments/Updates
6.12 Boehringer Ingelheim Group
6.12.1 Boehringer Ingelheim Group Corporation Information
6.12.2 Boehringer Ingelheim Group Jakinibs Description and Business Overview
6.12.3 Boehringer Ingelheim Group Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Boehringer Ingelheim Group Jakinibs Product Portfolio
6.12.5 Boehringer Ingelheim Group Recent Developments/Updates
6.13 Teva Pharmaceutical
6.13.1 Teva Pharmaceutical Corporation Information
6.13.2 Teva Pharmaceutical Jakinibs Description and Business Overview
6.13.3 Teva Pharmaceutical Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Teva Pharmaceutical Jakinibs Product Portfolio
6.13.5 Teva Pharmaceutical Recent Developments/Updates
6.14 Kyowa Hakko Kirin Co. Ltd.
6.14.1 Kyowa Hakko Kirin Co. Ltd. Corporation Information
6.14.2 Kyowa Hakko Kirin Co. Ltd. Jakinibs Description and Business Overview
6.14.3 Kyowa Hakko Kirin Co. Ltd. Jakinibs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Kyowa Hakko Kirin Co. Ltd. Jakinibs Product Portfolio
6.14.5 Kyowa Hakko Kirin Co. Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Jakinibs Industry Chain Analysis
7.2 Jakinibs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Jakinibs Production Mode & Process
7.4 Jakinibs Sales and Marketing
7.4.1 Jakinibs Sales Channels
7.4.2 Jakinibs Distributors
7.5 Jakinibs Customers
8 Jakinibs Market Dynamics
8.1 Jakinibs Industry Trends
8.2 Jakinibs Market Drivers
8.3 Jakinibs Market Challenges
8.4 Jakinibs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Jakinibs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Jakinibs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Jakinibs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Jakinibs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Jakinibs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Jakinibs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Jakinibs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Jakinibs Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Jakinibs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Jakinibs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Jakinibs, Product Type & Application
Table 12. Global Key Manufacturers of Jakinibs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Jakinibs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Jakinibs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Jakinibs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Jakinibs Sales by Region (2019-2024) & (K Units)
Table 18. Global Jakinibs Sales Market Share by Region (2019-2024)
Table 19. Global Jakinibs Sales by Region (2025-2030) & (K Units)
Table 20. Global Jakinibs Sales Market Share by Region (2025-2030)
Table 21. Global Jakinibs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Jakinibs Revenue Market Share by Region (2019-2024)
Table 23. Global Jakinibs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Jakinibs Revenue Market Share by Region (2025-2030)
Table 25. North America Jakinibs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Jakinibs Sales by Country (2019-2024) & (K Units)
Table 27. North America Jakinibs Sales by Country (2025-2030) & (K Units)
Table 28. North America Jakinibs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Jakinibs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Jakinibs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Jakinibs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Jakinibs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Jakinibs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Jakinibs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Jakinibs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Jakinibs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Jakinibs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Jakinibs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Jakinibs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Jakinibs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Jakinibs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Jakinibs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Jakinibs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Jakinibs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Jakinibs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Jakinibs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Jakinibs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Jakinibs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Jakinibs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Jakinibs Sales (K Units) by Type (2019-2024)
Table 51. Global Jakinibs Sales (K Units) by Type (2025-2030)
Table 52. Global Jakinibs Sales Market Share by Type (2019-2024)
Table 53. Global Jakinibs Sales Market Share by Type (2025-2030)
Table 54. Global Jakinibs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Jakinibs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Jakinibs Revenue Market Share by Type (2019-2024)
Table 57. Global Jakinibs Revenue Market Share by Type (2025-2030)
Table 58. Global Jakinibs Price (USD/Unit) by Type (2019-2024)
Table 59. Global Jakinibs Price (USD/Unit) by Type (2025-2030)
Table 60. Global Jakinibs Sales (K Units) by Application (2019-2024)
Table 61. Global Jakinibs Sales (K Units) by Application (2025-2030)
Table 62. Global Jakinibs Sales Market Share by Application (2019-2024)
Table 63. Global Jakinibs Sales Market Share by Application (2025-2030)
Table 64. Global Jakinibs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Jakinibs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Jakinibs Revenue Market Share by Application (2019-2024)
Table 67. Global Jakinibs Revenue Market Share by Application (2025-2030)
Table 68. Global Jakinibs Price (USD/Unit) by Application (2019-2024)
Table 69. Global Jakinibs Price (USD/Unit) by Application (2025-2030)
Table 70. Astellas Pharma, Inc. Corporation Information
Table 71. Astellas Pharma, Inc. Description and Business Overview
Table 72. Astellas Pharma, Inc. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Astellas Pharma, Inc. Jakinibs Product
Table 74. Astellas Pharma, Inc. Recent Developments/Updates
Table 75. Eli Lilly and Co. Corporation Information
Table 76. Eli Lilly and Co. Description and Business Overview
Table 77. Eli Lilly and Co. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Eli Lilly and Co. Jakinibs Product
Table 79. Eli Lilly and Co. Recent Developments/Updates
Table 80. Incyte Corp. Corporation Information
Table 81. Incyte Corp. Description and Business Overview
Table 82. Incyte Corp. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Incyte Corp. Jakinibs Product
Table 84. Incyte Corp. Recent Developments/Updates
Table 85. Novartis AG Corporation Information
Table 86. Novartis AG Description and Business Overview
Table 87. Novartis AG Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Novartis AG Jakinibs Product
Table 89. Novartis AG Recent Developments/Updates
Table 90. Pfizer Inc. Corporation Information
Table 91. Pfizer Inc. Description and Business Overview
Table 92. Pfizer Inc. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Pfizer Inc. Jakinibs Product
Table 94. Pfizer Inc. Recent Developments/Updates
Table 95. GSK Corporation Information
Table 96. GSK Description and Business Overview
Table 97. GSK Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. GSK Jakinibs Product
Table 99. GSK Recent Developments/Updates
Table 100. Bristol Myers Squibb Co. Corporation Information
Table 101. Bristol Myers Squibb Co. Description and Business Overview
Table 102. Bristol Myers Squibb Co. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Bristol Myers Squibb Co. Jakinibs Product
Table 104. Bristol Myers Squibb Co. Recent Developments/Updates
Table 105. Baxter International, Inc. Corporation Information
Table 106. Baxter International, Inc. Description and Business Overview
Table 107. Baxter International, Inc. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Baxter International, Inc. Jakinibs Product
Table 109. Baxter International, Inc. Recent Developments/Updates
Table 110. Gilead Sciences, Inc. Corporation Information
Table 111. Gilead Sciences, Inc. Description and Business Overview
Table 112. Gilead Sciences, Inc. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Gilead Sciences, Inc. Jakinibs Product
Table 114. Gilead Sciences, Inc. Recent Developments/Updates
Table 115. AbbVie, Inc. Corporation Information
Table 116. AbbVie, Inc. Description and Business Overview
Table 117. AbbVie, Inc. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. AbbVie, Inc. Jakinibs Product
Table 119. AbbVie, Inc. Recent Developments/Updates
Table 120. Takeda Corporation Information
Table 121. Takeda Description and Business Overview
Table 122. Takeda Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Takeda Jakinibs Product
Table 124. Takeda Recent Developments/Updates
Table 125. Boehringer Ingelheim Group Corporation Information
Table 126. Boehringer Ingelheim Group Description and Business Overview
Table 127. Boehringer Ingelheim Group Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Boehringer Ingelheim Group Jakinibs Product
Table 129. Boehringer Ingelheim Group Recent Developments/Updates
Table 130. Teva Pharmaceutical Corporation Information
Table 131. Teva Pharmaceutical Description and Business Overview
Table 132. Teva Pharmaceutical Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Teva Pharmaceutical Jakinibs Product
Table 134. Teva Pharmaceutical Recent Developments/Updates
Table 135. Kyowa Hakko Kirin Co. Ltd. Corporation Information
Table 136. Kyowa Hakko Kirin Co. Ltd. Description and Business Overview
Table 137. Kyowa Hakko Kirin Co. Ltd. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Kyowa Hakko Kirin Co. Ltd. Jakinibs Product
Table 139. Kyowa Hakko Kirin Co. Ltd. Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Jakinibs Distributors List
Table 143. Jakinibs Customers List
Table 144. Jakinibs Market Trends
Table 145. Jakinibs Market Drivers
Table 146. Jakinibs Market Challenges
Table 147. Jakinibs Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Jakinibs
Figure 2. Global Jakinibs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Jakinibs Market Share by Type in 2023 & 2030
Figure 4. JAK1 Inhibitors Product Picture
Figure 5. JAK2 Inhibitors Product Picture
Figure 6. JAK3 Inhibitors Product Picture
Figure 7. Global Jakinibs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Jakinibs Market Share by Application in 2023 & 2030
Figure 9. Rheumatoid Arthritis
Figure 10. Inflammatory Bowel Disease
Figure 11. Psoriasis
Figure 12. Others
Figure 13. Global Jakinibs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Jakinibs Market Size (2019-2030) & (US$ Million)
Figure 15. Global Jakinibs Sales (2019-2030) & (K Units)
Figure 16. Global Jakinibs Average Price (USD/Unit) & (2019-2030)
Figure 17. Jakinibs Report Years Considered
Figure 18. Jakinibs Sales Share by Manufacturers in 2023
Figure 19. Global Jakinibs Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Jakinibs Players: Market Share by Revenue in 2023
Figure 21. Jakinibs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Jakinibs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Jakinibs Sales Market Share by Country (2019-2030)
Figure 24. North America Jakinibs Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Jakinibs Sales Market Share by Country (2019-2030)
Figure 28. Europe Jakinibs Revenue Market Share by Country (2019-2030)
Figure 29. Germany Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Jakinibs Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Jakinibs Revenue Market Share by Region (2019-2030)
Figure 36. China Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Jakinibs Sales Market Share by Country (2019-2030)
Figure 47. Latin America Jakinibs Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Jakinibs Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Jakinibs Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Jakinibs by Type (2019-2030)
Figure 57. Global Revenue Market Share of Jakinibs by Type (2019-2030)
Figure 58. Global Jakinibs Price (USD/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Jakinibs by Application (2019-2030)
Figure 60. Global Revenue Market Share of Jakinibs by Application (2019-2030)
Figure 61. Global Jakinibs Price (USD/Unit) by Application (2019-2030)
Figure 62. Jakinibs Value Chain
Figure 63. Jakinibs Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global Jakinibs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Jakinibs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Jakinibs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Jakinibs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Jakinibs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Jakinibs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Jakinibs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Jakinibs Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Jakinibs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Jakinibs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Jakinibs, Product Type & Application
Table 12. Global Key Manufacturers of Jakinibs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Jakinibs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Jakinibs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Jakinibs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Jakinibs Sales by Region (2019-2024) & (K Units)
Table 18. Global Jakinibs Sales Market Share by Region (2019-2024)
Table 19. Global Jakinibs Sales by Region (2025-2030) & (K Units)
Table 20. Global Jakinibs Sales Market Share by Region (2025-2030)
Table 21. Global Jakinibs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Jakinibs Revenue Market Share by Region (2019-2024)
Table 23. Global Jakinibs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Jakinibs Revenue Market Share by Region (2025-2030)
Table 25. North America Jakinibs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Jakinibs Sales by Country (2019-2024) & (K Units)
Table 27. North America Jakinibs Sales by Country (2025-2030) & (K Units)
Table 28. North America Jakinibs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Jakinibs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Jakinibs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Jakinibs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Jakinibs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Jakinibs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Jakinibs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Jakinibs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Jakinibs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Jakinibs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Jakinibs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Jakinibs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Jakinibs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Jakinibs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Jakinibs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Jakinibs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Jakinibs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Jakinibs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Jakinibs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Jakinibs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Jakinibs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Jakinibs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Jakinibs Sales (K Units) by Type (2019-2024)
Table 51. Global Jakinibs Sales (K Units) by Type (2025-2030)
Table 52. Global Jakinibs Sales Market Share by Type (2019-2024)
Table 53. Global Jakinibs Sales Market Share by Type (2025-2030)
Table 54. Global Jakinibs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Jakinibs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Jakinibs Revenue Market Share by Type (2019-2024)
Table 57. Global Jakinibs Revenue Market Share by Type (2025-2030)
Table 58. Global Jakinibs Price (USD/Unit) by Type (2019-2024)
Table 59. Global Jakinibs Price (USD/Unit) by Type (2025-2030)
Table 60. Global Jakinibs Sales (K Units) by Application (2019-2024)
Table 61. Global Jakinibs Sales (K Units) by Application (2025-2030)
Table 62. Global Jakinibs Sales Market Share by Application (2019-2024)
Table 63. Global Jakinibs Sales Market Share by Application (2025-2030)
Table 64. Global Jakinibs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Jakinibs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Jakinibs Revenue Market Share by Application (2019-2024)
Table 67. Global Jakinibs Revenue Market Share by Application (2025-2030)
Table 68. Global Jakinibs Price (USD/Unit) by Application (2019-2024)
Table 69. Global Jakinibs Price (USD/Unit) by Application (2025-2030)
Table 70. Astellas Pharma, Inc. Corporation Information
Table 71. Astellas Pharma, Inc. Description and Business Overview
Table 72. Astellas Pharma, Inc. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Astellas Pharma, Inc. Jakinibs Product
Table 74. Astellas Pharma, Inc. Recent Developments/Updates
Table 75. Eli Lilly and Co. Corporation Information
Table 76. Eli Lilly and Co. Description and Business Overview
Table 77. Eli Lilly and Co. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Eli Lilly and Co. Jakinibs Product
Table 79. Eli Lilly and Co. Recent Developments/Updates
Table 80. Incyte Corp. Corporation Information
Table 81. Incyte Corp. Description and Business Overview
Table 82. Incyte Corp. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Incyte Corp. Jakinibs Product
Table 84. Incyte Corp. Recent Developments/Updates
Table 85. Novartis AG Corporation Information
Table 86. Novartis AG Description and Business Overview
Table 87. Novartis AG Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Novartis AG Jakinibs Product
Table 89. Novartis AG Recent Developments/Updates
Table 90. Pfizer Inc. Corporation Information
Table 91. Pfizer Inc. Description and Business Overview
Table 92. Pfizer Inc. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Pfizer Inc. Jakinibs Product
Table 94. Pfizer Inc. Recent Developments/Updates
Table 95. GSK Corporation Information
Table 96. GSK Description and Business Overview
Table 97. GSK Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. GSK Jakinibs Product
Table 99. GSK Recent Developments/Updates
Table 100. Bristol Myers Squibb Co. Corporation Information
Table 101. Bristol Myers Squibb Co. Description and Business Overview
Table 102. Bristol Myers Squibb Co. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Bristol Myers Squibb Co. Jakinibs Product
Table 104. Bristol Myers Squibb Co. Recent Developments/Updates
Table 105. Baxter International, Inc. Corporation Information
Table 106. Baxter International, Inc. Description and Business Overview
Table 107. Baxter International, Inc. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Baxter International, Inc. Jakinibs Product
Table 109. Baxter International, Inc. Recent Developments/Updates
Table 110. Gilead Sciences, Inc. Corporation Information
Table 111. Gilead Sciences, Inc. Description and Business Overview
Table 112. Gilead Sciences, Inc. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Gilead Sciences, Inc. Jakinibs Product
Table 114. Gilead Sciences, Inc. Recent Developments/Updates
Table 115. AbbVie, Inc. Corporation Information
Table 116. AbbVie, Inc. Description and Business Overview
Table 117. AbbVie, Inc. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. AbbVie, Inc. Jakinibs Product
Table 119. AbbVie, Inc. Recent Developments/Updates
Table 120. Takeda Corporation Information
Table 121. Takeda Description and Business Overview
Table 122. Takeda Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Takeda Jakinibs Product
Table 124. Takeda Recent Developments/Updates
Table 125. Boehringer Ingelheim Group Corporation Information
Table 126. Boehringer Ingelheim Group Description and Business Overview
Table 127. Boehringer Ingelheim Group Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Boehringer Ingelheim Group Jakinibs Product
Table 129. Boehringer Ingelheim Group Recent Developments/Updates
Table 130. Teva Pharmaceutical Corporation Information
Table 131. Teva Pharmaceutical Description and Business Overview
Table 132. Teva Pharmaceutical Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Teva Pharmaceutical Jakinibs Product
Table 134. Teva Pharmaceutical Recent Developments/Updates
Table 135. Kyowa Hakko Kirin Co. Ltd. Corporation Information
Table 136. Kyowa Hakko Kirin Co. Ltd. Description and Business Overview
Table 137. Kyowa Hakko Kirin Co. Ltd. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Kyowa Hakko Kirin Co. Ltd. Jakinibs Product
Table 139. Kyowa Hakko Kirin Co. Ltd. Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Jakinibs Distributors List
Table 143. Jakinibs Customers List
Table 144. Jakinibs Market Trends
Table 145. Jakinibs Market Drivers
Table 146. Jakinibs Market Challenges
Table 147. Jakinibs Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Jakinibs
Figure 2. Global Jakinibs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Jakinibs Market Share by Type in 2023 & 2030
Figure 4. JAK1 Inhibitors Product Picture
Figure 5. JAK2 Inhibitors Product Picture
Figure 6. JAK3 Inhibitors Product Picture
Figure 7. Global Jakinibs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Jakinibs Market Share by Application in 2023 & 2030
Figure 9. Rheumatoid Arthritis
Figure 10. Inflammatory Bowel Disease
Figure 11. Psoriasis
Figure 12. Others
Figure 13. Global Jakinibs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Jakinibs Market Size (2019-2030) & (US$ Million)
Figure 15. Global Jakinibs Sales (2019-2030) & (K Units)
Figure 16. Global Jakinibs Average Price (USD/Unit) & (2019-2030)
Figure 17. Jakinibs Report Years Considered
Figure 18. Jakinibs Sales Share by Manufacturers in 2023
Figure 19. Global Jakinibs Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Jakinibs Players: Market Share by Revenue in 2023
Figure 21. Jakinibs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Jakinibs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Jakinibs Sales Market Share by Country (2019-2030)
Figure 24. North America Jakinibs Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Jakinibs Sales Market Share by Country (2019-2030)
Figure 28. Europe Jakinibs Revenue Market Share by Country (2019-2030)
Figure 29. Germany Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Jakinibs Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Jakinibs Revenue Market Share by Region (2019-2030)
Figure 36. China Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Jakinibs Sales Market Share by Country (2019-2030)
Figure 47. Latin America Jakinibs Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Jakinibs Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Jakinibs Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Jakinibs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Jakinibs by Type (2019-2030)
Figure 57. Global Revenue Market Share of Jakinibs by Type (2019-2030)
Figure 58. Global Jakinibs Price (USD/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Jakinibs by Application (2019-2030)
Figure 60. Global Revenue Market Share of Jakinibs by Application (2019-2030)
Figure 61. Global Jakinibs Price (USD/Unit) by Application (2019-2030)
Figure 62. Jakinibs Value Chain
Figure 63. Jakinibs Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232